2nd Quarter - Amendment

SHIRE PHARMACEUTICALS LLC for SHIRE PHARMACEUTICALS LLC

Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 22, 2013 $250,000 Replaced
2nd Quarter - Amendment (this page) Oct 2, 2013 $140,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

orphan drug tax credt; issues surrounding ADHD; ESRD PPS; mental health awareness, identification and treatment;binge eating disorder; drug shortages; DEA quotas; FDA funding; Trial and Experimental Studies Transparency Act; pharmaceutical and biotech related legislation; health care reform/FDASIA implementation

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —
MARK LENKER New Senior Legis. Asst., Rep.Curt Weldon

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.